Skip to main content
Clinical Trials/NCT04066413
NCT04066413
Terminated
Not Applicable

Growth and Tolerance Trial in Healthy Infants on Infant Formula Supplemented With a Human Milk Oligosaccharide

FrieslandCampina1 site in 1 country265 target enrollmentSeptember 23, 2019
ConditionsHealthy Growth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy Growth
Sponsor
FrieslandCampina
Enrollment
265
Locations
1
Primary Endpoint
Growth
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The aim of the study is to compare growth of healthy infants fed an infant formula supplemented with a human milk oligosaccharide to that of infants on standard formula.

Registry
clinicaltrials.gov
Start Date
September 23, 2019
End Date
January 26, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
FrieslandCampina
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Gestational age ≥ 37 weeks
  • Birth weight ≥ 2500 grams
  • No recognized diseases (such as cardiac, pulmonary, gastrointestinal, renal or genetic diseases)
  • Boys and girls
  • Recruited \< 1 month/age
  • Being available for follow up until the age of 4 months
  • Exclusive formula feeding or exclusive breast feeding at time of recruitment

Exclusion Criteria

  • Gestational age \<37 weeks
  • Birth weight \<2500 grams
  • Severe acquired or congenital diseases, mental or physical disorders
  • Illness at screening/ inclusion
  • Incapability of parents/caregivers to comply with the study protocol
  • Received antibiotics within the first month of life
  • Not tolerating standard cow's milk based infant formula
  • Participation in another clinical trial
  • Maternal illicit drug use during pregnancy or post-partum period
  • Parent/caregiver does not have a cell phone to use for filling out questionnaires

Outcomes

Primary Outcomes

Growth

Time Frame: From enrollment until end of the 3 month-study

Infant growth measured as body weight gain per day

Secondary Outcomes

  • Weight(Monthly, from enrollment until end of the 3 month-study)
  • Head circumference(Monthly, from enrollment until end of the 3 month-study)
  • Recumbent length(Monthly, from enrollment until end of the 3 month-study)
  • Anthropometry z-scores(Monthly, from enrollment until end of the 3 month-study)
  • Formula tolerance(Monthly, from enrollment until end of the 3 month-study)
  • Gastro-intestinal comfort(Monthly, from enrollment until end of the 3 month-study)

Study Sites (1)

Loading locations...

Similar Trials